Cancer as a complex genetic trait: Tumor susceptibility in humans and mouse models

Cell

Volumn 108, Issue 2, 2002, Pages 145-152

  Balmain, Allan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYLNITROSOUREA;

ALLELE; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; DNA MODIFICATION; GENE INTERACTION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENOME; HUMAN; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; REVIEW;

EID: 0037169357     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(02)00622-0     Document Type: Review

References (57)

1. Cyclin D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer
2. Carcinogenesis in mouse and human cells: Parallels and paradoxes
3. Cancer resistance genes in mice: Models for the study of tumour modifiers
4. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma
5. A computational analysis of whole-genome expression data reveals chromosomal domains of gene expression
6. The Mom1AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64
7. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis
8. Experimental strategies for the genetic dissection of complex traits in animal models
9. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse
10. A systematic review of genetic polymorphisms and breast cancer risk
11. The murine gene p27Kip1 is haplo-insufficient for tumour suppression
12. Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse
13. High frequency of interactions between lung cancer susceptibility genes in the mouse: Mapping of Sluc5 to Sluc14
14. Finding the molecular basis of quantitative traits: Successes and pitfalls
15. Disease-related versus polymorphic mutations in human mitochondrial tRNAs. Where is the difference?
16. Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients
17. In silico mapping of complex disease-related traits in mice
18. Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells
19. Genome-tagged mice (GTM): Two sets of genome-wide congenic strains
20. Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas
21. Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer
22. An association between the risk of cancer and mutations in the HRAS1 minisatellite locus
23. Prospects for whole-genome linkage disequilibrium mapping of common disease
24. A Major effect QTL determined by multiple genes in epileptic EL mice
25. Environmental and heritable factors in the causation of cancer - Analyses of cohorts of twins from Sweden, Denmark, and Finland
26. Allele-specific loss or imbalance of chromosomes 9, 15, and 16 in B-cell tumors from interspecific F1 hybrid mice carrying Emu-c-myc or N-myc transgenes
27. Quantitative trait loci in Drosophila
28. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of Apc/Min-induced intestinal neoplasia
29. Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites
30. Linkage disequilibrium and physical mapping of Pas1 in mice
31. Susceptibility to testicular germ-cell tumours in a 129. MOLF-Chr 19 chromosome substitution strain
32. The major murine systemic lupus erythematosis locus, Sle1, is a cluster of functionally related genes
33. From the cover: A method for fine mapping quantitative trait loci in outbred animal stocks
34. Modifier genes in mice and humans
35. The roads from phenotypic variation to gene discovery: Mutagenesis versus QTLs
36. A subset of skin tumor modifier loci determines survival time of tumor-bearing mice
37. Epistatic interactions between skin tumor modifier loci in interspecific (spretus/musculus) backcross mice
38. Breast cancer genetics: What we know and what we need
39. Genetics of prostate cancer too many loci, too few genes
40. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus
41. Cancer genetics
42. Mouse mammary tumor virus/v-Ha-ras transgene-induced mammary tumors exhibit strain-specific allelic loss on mouse chromosome 4
43. Chromosome engineering in mice
44. Linkage disequilibrium in the human genome
45. Generation of mice from wild-type and targeted ES cells by nuclear cloning
46. The future of genetic studies of complex human diseases
47. DNA sequence evolution: The sounds of silence
48. Molecular dissection of a major gene effect on a quantitative trait: The level of alcohol dehydrogenase expression in Drosophila melanogaster
49. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene
50. Genetics of susceptibility to radiation-induced lymphomas, leukemias and lung tumors studied in recombinant congenic strains
51. High-resolution mapping of quantitative trait loci in outbred mice
52. Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency
53. Four new colon cancer susceptibility loci, Scc6 to Scc9 in the mouse
54. Gene interaction and single gene effects in colon tumour susceptibility in mice
55. Genic and organismic selection
56. A draft annotation and overview of the human genome
57. Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility